SARS-CoV-2, HIV, and HPV: Convergent evolution of selective regulation of cGAS-STING signaling

J Med Virol. 2023 Jan;95(1):e28220. doi: 10.1002/jmv.28220. Epub 2022 Oct 26.

Abstract

Recognizing aberrant cytoplasmic double-stranded DNA and stimulating innate immunity is essential for the host's defense against viruses and tumors. Cyclic GMP-AMP (cGAMP) synthase (cGAS) is a cytosolic DNA sensor that synthesizes the second messenger 2'3'-cGAMP and subsequently activates stimulator of interferon genes (STING)-mediated activation of TANK-binding kinase 1 (TBK1)/interferon regulatory factor 3 (IRF3) and the production of type I interferon (IFN-I). Both the cGAS-STING-mediated IFN-I antiviral defense and the countermeasures developed by diverse viruses have been extensively studied. However, recent studies have revealed a convergent evolutionary feature of severe acute respiratory syndrome coronavirus 2 and human immunodeficiency virus (HIV) viral proteins in terms of the selective regulation of cGAS-STING-mediated nuclear factor-κB (NF-κB) signaling without any effect on cGAS-STING-mediated TBK1/IRF3 activation and IFN production. The potential beneficial effect of this cGAS-STING-mediated, NF-κB-dependent antiviral effect, and the possible detrimental effect of IFN-I in the pathogenesis of coronavirus disease 2019 and HIV infection deserve more attention and future investigation.

Keywords: cGAS-STING signaling; convergent evolution; viruses.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents
  • COVID-19*
  • DNA / metabolism
  • HIV Infections*
  • Humans
  • Immunity, Innate
  • NF-kappa B / metabolism
  • Nucleotidyltransferases
  • Papillomavirus Infections*
  • SARS-CoV-2 / genetics

Substances

  • NF-kappa B
  • Nucleotidyltransferases
  • DNA
  • Antiviral Agents